NICE Reconsider Santen’s Keratitis Drug

After an initial rejection earlier this year, NICE has published the final draft guidance backing the use of Santen’s eye drug Ikervis on the NHS in England and Wales. The Institute is now endorsing Ikervis (ciclosporin) to treat severe keratitis in adults with dry eye disease that has not improved despite treatment with artificial tears.

Continue Reading